Physician profile
Ryan Park
NPI 1760738728
$4,685.78
in general payments reported to CMS, 2019-2025
37 companies · $1,570 in 2025
The $1,570 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $296 · 2022: $307 · 2023: $1,351 · 2024: $1,163 · 2025: $1,570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,237 · Travel and Lodging: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,236.69 |
| Travel and Lodging | $846.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,045.34 | 2023 | Intracept |
| Boston Scientific Corporation | $543.75 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept, General - Therapies |
| Abbvie INC. | $531.75 | 2021-2025 | |
| Abbott Laboratories | $470.44 | 2021-2025 | Perclose Prostyle, Perclose Proglide, Proclaim |
| Lilly USA, LLC | $204.27 | 2021-2025 | Kisunla, Amyvid, Emgality |
| Pfizer INC. | $192.02 | 2023-2025 | |
| Medtronic, INC. | $189.20 | 2022-2024 | Intellis Adaptivestim, Signia, Synchromedii |
| Kyowa Kirin, INC. | $142.15 | 2024-2025 | Nourianz |
| Painteq LLC | $120.49 | 2024 | Painteq |
| Saluda Medical Americas, INC. | $111.65 | 2024-2025 | Evoke |
| Argenx US, INC. | $108.21 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Grt US Holding, INC. | $90.00 | 2021-2022 | |
| Lundbeck LLC | $86.88 | 2024-2025 | Vyepti, Rexulti |
| Emd Serono, INC. | $82.19 | 2024 | |
| Merz Pharmaceuticals, LLC | $67.69 | 2024-2025 | Xeomin, Inbrija, Ampyra |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.